Yehudith Assouline-Dayan

Statistics

Publications

Citations

1.9K

H-Index

Active since

2002

Affiliations

University of North Carolina at Chapel Hill(Current)

Cincinnati Children's Hospital Medical Center

University of Cincinnati

University of Bern

Institute of Social and Preventive Medicine

Yehudith Assouline-Dayan is an author at University of North Carolina at Chapel Hill specializing in pharmacotherapy, eosinophilic disorders, and eosinophilic gastrointestinal disorders.

ORCID

Publications per year

2002–2020

Publications

Pathogenesis and natural history of osteonecrosis

Yehudith Assouline-Dayan, Christopher Chang, Adam Greenspan et al. · Seminars in Arthritis and Rheumatism · 2002 · 786 citations

Medicine, Orthopaedic Surgery, Orthopedic Surgery +11

Efficacy of Dupilumab in a Phase 2 Randomized Trial of Adults With Active Eosinophilic Esophagitis

Ikuo Hirano, Evan S. Dellon, Jennifer D. Hamilton et al. · Gastroenterology · 2019 · 451 citations · Full text

Life Sciences, Immunology, Pharmacotherapy +16

RPC4046, a Monoclonal Antibody Against IL13, Reduces Histologic and Endoscopic Activity in Patients With Eosinophilic Esophagitis

Ikuo Hirano, Margaret H. Collins, Yehudith Assouline-Dayan et al. · Gastroenterology · 2018 · 267 citations · Full text

Life Sciences, Immunology, Pharmacotherapy +17

Budesonide Oral Suspension Improves Symptomatic, Endoscopic, and Histologic Parameters Compared With Placebo in Patients With Eosinophilic Esophagitis

Evan S. Dellon, David A. Katzka, Margaret H. Collins et al. · Gastroenterology · 2016 · 228 citations · Full text

Medicine, Pharmacotherapy, Dysphagia +16

Long-term Efficacy and Tolerability of RPC4046 in an Open-Label Extension Trial of Patients With Eosinophilic Esophagitis

Evan S. Dellon, Margaret H. Collins, Marc E. Rothenberg et al. · Clinical Gastroenterology and Hepatology · 2020 · 98 citations · Full text

Medicine, Clinical Sciences, Pharmacotherapy +15

1–5 of 6